Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CALGARY, Alberta, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) announces, further to its news release of September 5,...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF...
-
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
-
CHICAGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The National Association of Realtors® today announced a new series of consumer resources designed to help agents who are Realtors® empower home buyers and...
-
Washington, D.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Key Highlights Existing-home sales retreated 2.5% in August to a seasonally adjusted annual rate of 3.86 million. Sales slid 4.2% from...
-
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 200,000,000 EURO FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP IV ECAPS") ISSUER: LEHMAN BROTHERS...
-
TSX Approves ECN Capital’s Normal Course Issuer Bids for Common Shares and Series C Preferred Shares
TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ECN Capital Corp. (TSX: ECN, ECN.PR.C) (“ECN Capital” or the “Company”) today announced that the Toronto Stock Exchange (the “TSX”) has approved the...
-
SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
-
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...